Insulin-Like Growth Factor I (IGF I) has marked effects on cellular proliferation and differentiation through both endocrine and autocrine/paracrine mechanisms. It is produced and secreted by vascular cells in vitro and exerts its effects after binding to a specific high- affinity membrane receptor. Platelet-derived growth factor (PDGF) may be released from aggregating platelets/monocytes at sites of endothelial injury/dysfunction as well as from vascular smooth muscle cells (VSMC) and modulates IGF I gene expression. The primary focus of this proposal is to study the role of IGF I and of its receptor in vascular growth responses to a variety of stimuli and to determine whether blocking the IGF I receptor alters vessel wall hypertrophy/hyperplasia.
Specific Aims will include: 1) Characterization of the regulation of IGF I gene expression in cultured vascular smooth muscle cells and in aorta by PDGF. 2) Analysis of IGF I receptor gene expression and binding in vitro and in vivo, its regulation by PDGF and its role in the remodeling of the arterial wall seen in aortic, coarctation hypertension in the rat and following balloon-injury of the rat aorta. 3) Development of specific blocking antibodies against the IGF I receptor to study their effects in vitro and to determine whether blocking IGF I binding in vivo in the rat alters the hypertrophic/ hyperplastic response of the arterial wall to increased blood pressure and attenuates the proliferative neointimal response to balloon-injury of the rat aorta. 4) Study ICF I and ICF I receptor gene expression in developing myocardial collateral arteries in the dog. This proposal directly addresses the role of IGF I and its receptor in growth of the arterial wall in response to increased blood pressure and following mechanical injury and will define molecular mechanisms whereby PDGF modulates gene expression of IGF I and its receptor. These issues are key to understanding the pathophysiology of the arterial remodeling present in hypertension and following balloon-injury and should provide major insights into the mechanisms regulating the growth of VSMC in disease states such as atherosclerosis. Defining the effect of IGF I receptor blockade should permit us to develop therapeutic approaches targeted toward specific clinical problems such as post-angioplasty restenosis and accelerated atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL047035-02
Application #
3366231
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
1991-08-01
Project End
1995-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Anwar, A; Zahid, A A; Scheidegger, K J et al. (2002) Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 105:1220-5
Sayeski, P P; Ali, M S; Frank, S J et al. (2001) The angiotensin II-dependent nuclear translocation of Stat1 is mediated by the Jak2 protein motif 231YRFRR. J Biol Chem 276:10556-63
Giraud, S; Greco, A; Brink, M et al. (2001) Translation initiation of the insulin-like growth factor I receptor mRNA is mediated by an internal ribosome entry site. J Biol Chem 276:5668-75
Okura, Y; Brink, M; Zahid, A A et al. (2001) Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J Mol Cell Cardiol 33:1777-89
Brink, M; Price, S R; Chrast, J et al. (2001) Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 142:1489-96
Keller, P F; Verin, V; Ziegler, T et al. (2001) Gamma-irradiation markedly inhibits the hydrated collagen gel contradiction by arterial smooth muscle cells. J Investig Med 49:258-64
Du, J; Brink, M; Peng, T et al. (2001) Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle: characterization of the signaling pathway. Circ Res 88:1044-52
Scheidegger, K J; James, R W; Delafontaine, P (2000) Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. J Biol Chem 275:26864-9
Anwar, A; Zahid, A A; Phillips, L et al. (2000) Insulin-like growth factor binding protein-4 expression is decreased by angiotensin II and thrombin in rat aortic vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:370-6
Delafontaine, P; Brink, M (2000) The growth hormone and insulin-like growth factor 1 axis in heart failure. Ann Endocrinol (Paris) 61:22-6

Showing the most recent 10 out of 38 publications